Snap-on Other Non-Current Liabilities decreased by 0.7% to $97.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.8%, from $93.20M to $97.70M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows relatively stable performance with a 0.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $100.90M | $100.90M | $98.50M | $97.90M | $95.10M | $93.30M | $89.30M | $85.10M | $84.40M | $87.00M | $82.70M | $87.40M | $89.60M | $86.80M | $87.90M | $92.90M | $93.20M | $93.30M | $97.00M | $98.40M | $97.70M |
| QoQ Change | — | +0.0% | -2.4% | -0.6% | -2.9% | -1.9% | -4.3% | -4.7% | -0.8% | +3.1% | -4.9% | +5.7% | +2.5% | -3.1% | +1.3% | +5.7% | +0.3% | +0.1% | +4.0% | +1.4% | -0.7% |
| YoY Change | — | — | — | — | -5.7% | -7.5% | -9.3% | -13.1% | -11.3% | -6.8% | -7.4% | +2.7% | +6.2% | -0.2% | +6.3% | +6.3% | +4.0% | +7.5% | +10.4% | +5.9% | +4.8% |